(S)-nicotine increases expression ISO RGD:1345184 6480464 Nicotine results in increased expression of CBL mRNA CTD PMID:18247414 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CBL mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1561386 6480464 Ethinyl Estradiol results in increased expression of CBL mRNA CTD PMID:29097150 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBL mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1345184 6480464 Estradiol results in increased expression of CBL mRNA CTD PMID:23019147 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression EXP 6480464 Metribolone results in increased expression of CBL mRNA CTD PMID:16301331 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBL mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1561386 6480464 Tetrachlorodibenzodioxin results in decreased expression of CBL mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1561386 6480464 Tetrachlorodibenzodioxin results in increased expression of CBL mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases phosphorylation ISO RGD:1561386 6480464 Tetrachlorodibenzodioxin results in decreased phosphorylation of CBL protein CTD PMID:9918770 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1561386 6480464 CBL protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [GRB2 protein binds to SOS1 protein]], CBL protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [SHC1 protein binds to [GRB2 protein binds to SOS1 protein]]] CTD PMID:9918770 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CBL mRNA CTD PMID:21570461 2-methylcholine affects expression ISO RGD:1345184 6480464 beta-methylcholine affects the expression of CBL mRNA CTD PMID:21179406 2-naphthylamine increases expression ISO RGD:1345184 6480464 2-Naphthylamine results in increased expression of CBL mRNA CTD PMID:18247414 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CBL mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1561386 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CBL mRNA CTD PMID:30071829 acrolein multiple interactions ISO RGD:1345184 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CBL mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CBL mRNA CTD PMID:32699268 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CBL mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:1345184 6480464 Aflatoxin B1 results in increased expression of CBL mRNA CTD PMID:21641981 all-trans-retinoic acid increases expression ISO RGD:1345184 6480464 Tretinoin results in increased expression of CBL mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1345184 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CBL mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CBL mRNA CTD PMID:32699268 amphetamine decreases expression ISO RGD:1561386 6480464 Amphetamine results in decreased expression of CBL mRNA CTD PMID:30779732 arsenite(3-) increases phosphorylation EXP 6480464 arsenite results in increased phosphorylation of CBL protein CTD PMID:14511371 arsenite(3-) multiple interactions ISO RGD:1345184 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CBL mRNA] CTD PMID:32406909 arsenite(3-) multiple interactions EXP 6480464 tyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CBL protein] CTD PMID:14511371 arsenous acid multiple interactions ISO RGD:1345184 6480464 [Bortezomib results in decreased activity of CBL protein] promotes the reaction [Arsenic Trioxide results in increased activity of AKT1 protein] CTD PMID:19457607 arsenous acid increases expression ISO RGD:1345184 6480464 Arsenic Trioxide results in increased expression of CBL protein CTD PMID:19457607 benzo[a]pyrene increases expression ISO RGD:1345184 6480464 Benzo(a)pyrene results in increased expression of CBL mRNA CTD PMID:18247414 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345184 6480464 7 more ... CTD PMID:20018196 bisphenol A decreases expression ISO RGD:1561386 6480464 bisphenol A results in decreased expression of CBL mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1345184 6480464 bisphenol A results in increased expression of CBL mRNA CTD PMID:33670352 bisphenol A affects expression ISO RGD:1561386 6480464 bisphenol A affects the expression of CBL mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:1561386 6480464 bisphenol A results in increased expression of CBL mRNA CTD PMID:29097150 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of CBL promoter CTD PMID:27334623 bortezomib multiple interactions ISO RGD:1345184 6480464 [Bortezomib results in decreased activity of CBL protein] promotes the reaction [arsenic trioxide results in increased activity of AKT1 protein] CTD PMID:19457607 cadmium atom multiple interactions ISO RGD:1345184 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CBL mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1345184 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CBL mRNA CTD PMID:35301059 carbamazepine affects expression ISO RGD:1345184 6480464 Carbamazepine affects the expression of CBL mRNA CTD PMID:24752500 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of CBL mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1345184 6480464 CGP 52608 promotes the reaction [RORA protein binds to CBL gene] CTD PMID:28238834 chloroprene increases expression ISO RGD:1561386 6480464 Chloroprene results in increased expression of CBL mRNA CTD PMID:23125180 cisplatin decreases expression ISO RGD:1345184 6480464 Cisplatin results in decreased expression of CBL mRNA CTD PMID:27594783 copper(II) sulfate increases expression ISO RGD:1345184 6480464 Copper Sulfate results in increased expression of CBL mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1345184 6480464 Cyclosporine results in increased expression of CBL mRNA CTD PMID:25562108 diarsenic trioxide multiple interactions ISO RGD:1345184 6480464 [Bortezomib results in decreased activity of CBL protein] promotes the reaction [Arsenic Trioxide results in increased activity of AKT1 protein] CTD PMID:19457607 diarsenic trioxide increases expression ISO RGD:1345184 6480464 Arsenic Trioxide results in increased expression of CBL protein CTD PMID:19457607 diclofenac affects expression ISO RGD:1345184 6480464 Diclofenac affects the expression of CBL mRNA CTD PMID:24752500 dicrotophos increases expression ISO RGD:1345184 6480464 dicrotophos results in increased expression of CBL mRNA CTD PMID:28302478 dieldrin decreases response to substance ISO RGD:1345184 6480464 CBL gene mutant form results in decreased susceptibility to Dieldrin CTD PMID:32421776 diuron decreases expression ISO RGD:1561386 6480464 Diuron results in decreased expression of CBL mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1345184 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBL mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1345184 6480464 Doxorubicin results in decreased expression of CBL mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO RGD:1345184 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CBL protein CTD PMID:23301498 ethanol multiple interactions ISO RGD:1561386 6480464 Ethanol inhibits the reaction [INS1 protein results in increased phosphorylation of and affects the localization of CBL protein] CTD PMID:16105861 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CBL mRNA CTD PMID:30319688 fipronil increases expression ISO RGD:1561386 6480464 fipronil results in increased expression of CBL mRNA CTD PMID:34044035 flutamide decreases expression ISO RGD:1561386 6480464 Flutamide results in decreased expression of CBL mRNA CTD PMID:16301331 flutamide multiple interactions EXP 6480464 [CBL protein affects the susceptibility to Flutamide] which affects the expression of BIRC3 mRNA more ... CTD PMID:16301331 flutamide multiple interactions ISO RGD:1561386 6480464 Flutamide results in decreased expression of and results in decreased phosphorylation of CBL protein CTD PMID:16301331 flutamide affects expression EXP 6480464 Flutamide affects the expression of CBL mRNA CTD PMID:16301331 geldanamycin increases expression ISO RGD:1345184 6480464 geldanamycin results in increased expression of CBL mRNA CTD PMID:26705709 ivermectin decreases expression ISO RGD:1345184 6480464 Ivermectin results in decreased expression of CBL protein CTD PMID:32959892 lead diacetate multiple interactions ISO RGD:1561386 6480464 CBL protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein] CTD PMID:17298174 lead diacetate increases phosphorylation ISO RGD:1561386 6480464 lead acetate results in increased phosphorylation of CBL protein CTD PMID:17298174 lead(0) multiple interactions ISO RGD:1561386 6480464 CBL protein affects the reaction [Lead results in decreased expression of PDGFRA protein] CTD PMID:17298174 lead(0) increases phosphorylation ISO RGD:1561386 6480464 Lead results in increased phosphorylation of CBL protein CTD PMID:17298174 lead(2+) multiple interactions ISO RGD:1561386 6480464 CBL protein affects the reaction [Lead results in decreased expression of PDGFRA protein] CTD PMID:17298174 lead(2+) increases phosphorylation ISO RGD:1561386 6480464 Lead results in increased phosphorylation of CBL protein CTD PMID:17298174 mercury dichloride multiple interactions EXP 6480464 Mercuric Chloride promotes the reaction [HCK protein results in increased phosphorylation of CBL protein] CTD PMID:10092522 mercury dichloride decreases expression ISO RGD:1345184 6480464 Mercuric Chloride results in decreased expression of CBL mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:1345184 6480464 methylmercuric chloride results in increased expression of CBL mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride multiple interactions ISO RGD:1345184 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBL mRNA CTD PMID:27188386 nicotine increases expression ISO RGD:1345184 6480464 Nicotine results in increased expression of CBL mRNA CTD PMID:18247414 nitrofen decreases expression ISO RGD:1561386 6480464 nitrofen results in decreased expression of CBL mRNA, nitrofen results in decreased expression of CBL protein CTD PMID:23143077 ozone multiple interactions ISO RGD:1345184 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CBL mRNA more ... CTD PMID:32699268 p-menthan-3-ol decreases expression ISO RGD:1345184 6480464 Menthol results in decreased expression of CBL mRNA CTD PMID:26760959 paracetamol increases expression ISO RGD:1345184 6480464 Acetaminophen results in increased expression of CBL mRNA CTD PMID:22230336 , PMID:29067470 paraquat multiple interactions ISO RGD:1561386 6480464 CBL protein affects the reaction [Paraquat results in decreased expression of PDGFRA protein] CTD PMID:17298174 paraquat increases phosphorylation ISO RGD:1561386 6480464 Paraquat results in increased phosphorylation of CBL protein CTD PMID:17298174 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CBL mRNA CTD PMID:23091169 phosphane affects expression ISO RGD:1561386 6480464 phosphine affects the expression of CBL mRNA CTD PMID:34427094 resveratrol decreases expression ISO RGD:1345184 6480464 resveratrol results in decreased expression of CBL mRNA CTD PMID:25667456 retinyl acetate increases expression EXP 6480464 retinol acetate results in increased expression of CBL mRNA CTD PMID:16772331 SB 431542 multiple interactions ISO RGD:1345184 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBL mRNA CTD PMID:27188386 silver atom decreases expression EXP 6480464 Silver results in decreased expression of CBL mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of CBL mRNA CTD PMID:27131904 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of CBL mRNA CTD PMID:21795629 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of CBL mRNA CTD PMID:21795629 thimerosal decreases expression ISO RGD:1345184 6480464 Thimerosal results in decreased expression of CBL mRNA CTD PMID:27188386 thioacetamide increases expression ISO RGD:1561386 6480464 Thioacetamide results in increased expression of CBL mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CBL mRNA CTD PMID:23409001 torcetrapib increases expression ISO RGD:1345184 6480464 torcetrapib results in increased expression of CBL mRNA CTD PMID:23228038 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of CBL mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CBL mRNA CTD PMID:28973697 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of CBL mRNA CTD PMID:30912803 urethane increases expression ISO RGD:1345184 6480464 Urethane results in increased expression of CBL mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1561386 6480464 Valproic Acid results in decreased expression of CBL mRNA CTD PMID:29427782 valproic acid affects splicing ISO RGD:1561386 6480464 Valproic Acid affects the splicing of CBL mRNA CTD PMID:29427782 vorinostat decreases expression ISO RGD:1345184 6480464 vorinostat results in decreased expression of CBL mRNA CTD PMID:27188386